Missed pediatric ophthalmology appointments can translate to poor vision care for the patient and lost hours and income for the ophthalmologist, but targeted strategies can help reduce no-show rates and ensure continuity of care. Source: AAO
An increased incidence of new-onset uveitis or uveitis relapse following COVID-19 vaccination has been noted in the literature. Proper timing of vaccination is key to minimizing risk of uveitis flares and worsening disease. Source: AAO
Patients with ocular mucous membrane pemphigoid (OcMMP) may benefit most from mycophenolate or a mycophenolate–rituximab combination treatment. Source: AAO
Despite ease of use, the Amsler grid may not have adequate sensitivity or specificity to make it a reliable at-home tool for monitoring the progression of AMD. Source: AAO
Changes in retinal vascular tissue could point to dementia, smoking in families increases the risk of myopia in their children, and patients prefer same-day postsurgical care to next-day care. Source: AAO
Tumor necrosis factor-alpha inhibitors adalimumab and infliximab are common therapies for noninfectious uveitis (NIU), but the presence of antidrug antibodies could result in lower circulating drug levels. Source: AAO
Ultrathin Descemet stripping automated endothelial keratoplasty (DSAEK) and Descemet membrane endothelial keratoplasty (DMEK) are similarly successful, but one may yield better BCVA. Source: AAO
Undergoing multiple intravitreal injections for age-related macular degeneration may have a positive impact on dry eye disease–related symptoms. Source: AAO
Tebentafusp appears to promote better overall survival than combined immune checkpoint blockage for certain patients with metastatic uveal melanoma. Source: AAO
Rates of advanced trauma care for firearms-related ocular injuries vary by age and race, visual disabilities increase the risk of cardiovascular disease in patients with AMD, and MIEBO, a new treatment for dry eye disease, is approved. Source: AAO